Bryologyx
Dr. Gelber is a leader in the discovery and development of immune therapeutics and diagnostics for cancer, autoimmune disease, allergies and infectious diseases. She has authored more than 70 patents/patent applications.
This person is not in the org chart
This person is not in any offices
Bryologyx
BryoLogyx is developing a new class of drugs to enhance the response rates and treatment durability of cancer immunotherapies.